Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by LeMaitre Vascular, Inc. on June 2, 2026. The filing details the results of shareholder votes on director elections, executive compensation, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
As of the record date (April 6, 2026), 22,847,798 shares were entitled to vote, with 21,336,301 shares present or represented by proxy. All three proposals were approved by a majority of votes cast:
- Proposal 1 (Election of Directors): Two Class II directors were elected for three-year terms.
- David B. Roberts: 18,888,412 votes for; 1,250,012 withheld.
- John A. Roush: 14,229,071 votes for; 5,909,353 withheld.
- Proposal 2 (Advisory Vote on Executive Compensation): Approved with 19,311,813 votes for and 813,052 votes against.
- Proposal 3 (Ratification of Auditor): Grant Thornton LLP was ratified for the year ending December 31, 2026, with 21,220,412 votes for and 108,474 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the tenure of the newly elected directors (David B. Roberts and John A. Roush) through the 2029 Annual Meeting.
- Confirm the appointment of Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2026.
- Note the significant number of shares withheld for John A. Roush (5,909,353) compared to David B. Roberts (1,250,012), indicating varying levels of shareholder support.
- Review the company's subsequent 10-K or 10-Q filings for financial performance data, as this 8-K contains no financial metrics.